Trump Administration Pauses Public Health Agency Operations, Delays Research Funding

The temporary freeze impacts federal health communications, scientific meetings, and grant reviews, raising concerns about public health and research progress.

President Trump issued executive orders halting communications, meetings, and hiring at major public health agencies, including the CDC, NIH, and FDA, to review protocols.
The NIH has paused grant review panels, delaying funding for research projects, including cancer research, which relies heavily on federal grants.
The CDC's Morbidity and Mortality Weekly Report, a critical resource for tracking disease outbreaks, was suspended for the first time in its 64-year history.
The freeze extends to scientific conferences and advisory committee meetings, such as those focused on vaccines and antibiotic resistance, potentially delaying critical public health initiatives.
Concerns are mounting over the long-term impact on research, public health communication, and the U.S.'s global leadership in biomedical science.